<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Amitriptyline - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/depressants/">Depressants</a> ‚Üí <span>Amitriptyline</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üíä Amitriptyline</h1>
        <h2 class="chemical-name">3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine</h2>
          
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Amitriptyline" 
                data-category="Depressants" 
                data-chemical="3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Brand Names</h4>
              <span>Elavil</span> ‚Ä¢ <span>Endep</span> ‚Ä¢ <span>Tryptanol</span> ‚Ä¢ <span>Laroxyl</span> ‚Ä¢ <span>Sarotex</span>
            </div>
            <div class="name-category">
              <h4>Generic Names</h4>
              <span>Amitriptyline HCl</span> ‚Ä¢ <span>Amitriptyline hydrochloride</span> ‚Ä¢ <span>AMT</span>
            </div>
            <div class="name-category">
              <h4>Street Names</h4>
              <span>Trips</span> ‚Ä¢ <span>Tricyclics</span> ‚Ä¢ <span>Sleepers</span> ‚Ä¢ <span>Downers</span>
            </div>
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>5-(3-Dimethylaminopropylidene)dibenzo[a,d]cycloheptene</span> ‚Ä¢ <span>TCA</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category depressant medical">Depressant/Medical</span>
          <span class="legal-status prescription">Prescription</span>
          <span class="duration long">12-24 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/amitriptyline.jpg" alt="Amitriptyline tablets" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÇ‚ÇÄH‚ÇÇ‚ÇÉN</p>
            <p>MW: 277.40 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pharmaceutical Forms</h4>
          <ul>
            <li><strong>Tablets:</strong> Round, film-coated, various colors (blue, yellow, brown)</li>
            <li><strong>Sizes:</strong> 10mg, 25mg, 50mg, 75mg, 100mg, 150mg tablets</li>
            <li><strong>Markings:</strong> Imprinted with strength and manufacturer codes</li>
            <li><strong>Appearance:</strong> Smooth, glossy coating, no score lines typically</li>
            <li><strong>Pure powder:</strong> White to off-white crystalline powder (rare)</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Common Tablet Identification</h4>
          <ul>
            <li><strong>10mg:</strong> Small blue or yellow tablets</li>
            <li><strong>25mg:</strong> Yellow tablets, often round</li>
            <li><strong>50mg:</strong> Brown or beige tablets</li>
            <li><strong>75mg:</strong> Orange or brown tablets</li>
            <li><strong>Generic variations:</strong> Colors and shapes vary by manufacturer</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Misidentification Risks</h4>
          <p><strong>Look-alikes:</strong> Can be confused with other antidepressants or anxiety medications</p>
          <p><strong>Counterfeit concerns:</strong> Rare but possible counterfeit versions with unknown contents</p>
          <p><strong>Similar medications:</strong> Other tricyclics (nortriptyline, doxepin) have different potencies</p>
          <p><strong>Street diverted:</strong> Legitimate pharmaceutical tablets diverted from medical use</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">10-25mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">25-50mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Therapeutic</span>
          <span class="dose-amount">50-150mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">High Therapeutic</span>
          <span class="dose-amount">150-300mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Dangerous</span>
          <span class="dose-amount">300mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="medical-dosing">
        <h4>Medical Dosing Guidelines</h4>
        <ul>
          <li><strong>Depression:</strong> Start 25mg daily, increase to 75-150mg daily</li>
          <li><strong>Chronic pain:</strong> 10-75mg daily (lower than antidepressant doses)</li>
          <li><strong>Migraine prevention:</strong> 10-50mg daily</li>
          <li><strong>Insomnia (off-label):</strong> 10-50mg before bed</li>
          <li><strong>Elderly patients:</strong> Start 10mg daily, maximum 100mg</li>
        </ul>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Dosage Warnings</h4>
        <ul>
          <li><strong>Overdose risk:</strong> >500mg can be fatal due to cardiac effects</li>
          <li><strong>Slow onset:</strong> Full antidepressant effects take 2-6 weeks</li>
          <li><strong>Withdrawal:</strong> Must taper slowly to avoid discontinuation syndrome</li>
          <li><strong>Individual variation:</strong> Metabolism varies greatly between individuals</li>
          <li><strong>Drug interactions:</strong> Many medications affect amitriptyline levels</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Medical Warning:</strong> Amitriptyline should only be used under medical supervision. It has a narrow therapeutic window and dangerous overdose potential. Recreational use is extremely risky.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (oral administration)</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-2:00</span>
          <span class="effect">Onset - sedation, dry mouth, drowsiness</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-8:00</span>
          <span class="effect">Peak - maximum sedation, potential euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-24:00</span>
          <span class="effect">Duration - continued sedation, hangover effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+24:00-48:00</span>
          <span class="effect">After effects - residual drowsiness, cognitive fog</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Therapeutic Effects</h4>
          <ul>
            <li>Mood stabilization (with chronic use)</li>
            <li>Anxiety reduction</li>
            <li>Pain relief (neuropathic pain)</li>
            <li>Sleep improvement</li>
            <li>Migraine prevention</li>
            <li>Reduction in depression symptoms</li>
          </ul>
        </div>
        
        <div class="effect-category recreational">
          <h4>üéØ Recreational Effects (Acute)</h4>
          <ul>
            <li>Heavy sedation and drowsiness</li>
            <li>Mild euphoria (high doses)</li>
            <li>Emotional numbing</li>
            <li>Dissociation from reality</li>
            <li>Dream-like state</li>
            <li>Anxiety relief</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Negative Effects & Side Effects</h4>
          <ul>
            <li>Severe dry mouth and constipation</li>
            <li>Blurred vision and light sensitivity</li>
            <li>Urinary retention</li>
            <li>Weight gain with chronic use</li>
            <li>Cognitive impairment and confusion</li>
            <li>Dangerous cardiac effects</li>
            <li>Severe hangover and grogginess</li>
            <li>Potential for seizures (overdose)</li>
          </ul>
        </div>
      </div>

      <div class="overdose-warning">
        <h4>üíÄ Overdose Signs - Medical Emergency</h4>
        <ul>
          <li><strong>Cardiac:</strong> Arrhythmias, QT prolongation, cardiac arrest</li>
          <li><strong>Neurological:</strong> Seizures, coma, delirium</li>
          <li><strong>Anticholinergic:</strong> Hyperthermia, dilated pupils, hot dry skin</li>
          <li><strong>Respiratory:</strong> Respiratory depression, aspiration risk</li>
          <li><strong>Fatal dose:</strong> As low as 10-20mg/kg (700-1400mg for 70kg person)</li>
        </ul>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Amitriptyline is a tricyclic antidepressant that blocks the reuptake of serotonin and norepinephrine, increasing their concentrations in synaptic clefts. It also has significant anticholinergic, antihistaminergic, and alpha-adrenergic blocking properties, which contribute to both therapeutic effects and side effects.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>SERT (5-HT transporter)</strong></span>
            <span class="affinity">High affinity (Ki: ~4 nM)</span>
            <span class="function">Antidepressant effects, mood regulation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>NET (NE transporter)</strong></span>
            <span class="affinity">High affinity (Ki: ~35 nM)</span>
            <span class="function">Antidepressant effects, pain relief</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Muscarinic receptors</strong></span>
            <span class="affinity">High affinity antagonist</span>
            <span class="function">Anticholinergic effects: dry mouth, constipation, blurred vision</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>H1 histamine receptors</strong></span>
            <span class="affinity">Very high affinity antagonist</span>
            <span class="function">Sedation, weight gain, drowsiness</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Œ±1-adrenergic receptors</strong></span>
            <span class="affinity">High affinity antagonist</span>
            <span class="function">Orthostatic hypotension, dizziness</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Sodium channels</strong></span>
            <span class="affinity">Blocks voltage-gated Na+ channels</span>
            <span class="function">Cardiac conduction effects, seizure risk, local anesthetic effects</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> Hepatic metabolism via CYP2D6, CYP1A2, CYP2C19 ‚Üí nortriptyline (active metabolite)</p>
          <p><strong>Active metabolite:</strong> Nortriptyline has similar but distinct pharmacological profile</p>
          <p><strong>Half-life:</strong> 10-50 hours (highly variable, longer in elderly)</p>
          <p><strong>Bioavailability:</strong> 30-60% oral (extensive first-pass metabolism)</p>
          <p><strong>Peak plasma:</strong> 2-8 hours after oral dose</p>
          <p><strong>Steady state:</strong> 5-7 days with daily dosing</p>
          <p><strong>Protein binding:</strong> 95% bound to plasma proteins</p>
        </div>

        <h4>Therapeutic vs. Toxic Mechanisms</h4>
        <div class="therapeutic-toxicity">
          <p><strong>Therapeutic window:</strong> Narrow - therapeutic effects at 75-300mg daily</p>
          <p><strong>Toxic effects:</strong> Begin around 500mg acute dose or high chronic levels</p>
          <p><strong>Cardiac toxicity:</strong> Sodium channel blockade causes conduction delays</p>
          <p><strong>CNS toxicity:</strong> Anticholinergic delirium, seizure threshold lowering</p>
          <p><strong>Individual variation:</strong> Poor CYP2D6 metabolizers at higher risk</p>
        </div>

        <h4>Tolerance & Dependence</h4>
        <ul>
          <li><strong>Physical dependence:</strong> Develops with chronic use, withdrawal syndrome on discontinuation</li>
          <li><strong>Tolerance:</strong> Develops to sedative effects, less to antidepressant effects</li>
          <li><strong>Withdrawal:</strong> Flu-like symptoms, mood changes, electric shock sensations</li>
          <li><strong>Psychological dependence:</strong> Possible with recreational use for sedation</li>
          <li><strong>Cross-tolerance:</strong> With other anticholinergic medications</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Extreme Dangers</h4>
          <ul>
            <li><strong>Cardiac toxicity:</strong> Fatal arrhythmias, sudden cardiac death</li>
            <li><strong>Overdose lethality:</strong> Low fatal dose, narrow margin of safety</li>
            <li><strong>Anticholinergic crisis:</strong> Hyperthermia, delirium, seizures</li>
            <li><strong>Respiratory depression:</strong> Especially combined with other depressants</li>
            <li><strong>Suicidal ideation:</strong> Increased risk in young adults during initial treatment</li>
            <li><strong>Withdrawal seizures:</strong> Risk with abrupt discontinuation</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Harm Reduction (Medical Use Only)</h4>
          <ul>
            <li>Only use under strict medical supervision</li>
            <li>Start with lowest possible dose</li>
            <li>Never combine with alcohol or other depressants</li>
            <li>Regular cardiac monitoring (ECG) during treatment</li>
            <li>Monitor for suicidal thoughts, especially initially</li>
            <li>Taper slowly when discontinuing</li>
            <li>Be aware of drug interactions</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <ul>
          <li>Recent myocardial infarction</li>
          <li>Heart block or arrhythmias</li>
          <li>Severe liver disease</li>
          <li>Closed-angle glaucoma</li>
          <li>Urinary retention</li>
          <li>Use with MAOIs (within 14 days)</li>
          <li>Known hypersensitivity to tricyclics</li>
        </ul>
      </div>

      <div class="emergency-protocol">
        <h4>üö® Overdose Emergency - Call 911 Immediately</h4>
        <ul>
          <li>Any chest pain or irregular heartbeat</li>
          <li>Seizures or convulsions</li>
          <li>Unconsciousness or unresponsiveness</li>
          <li>Severe confusion or delirium</li>
          <li>High fever (>103¬∞F/39.4¬∞C)</li>
          <li>Difficulty breathing</li>
        </ul>
        <p><strong>Treatment:</strong> Activated charcoal (if recent ingestion), cardiac monitoring, IV sodium bicarbonate for cardiac toxicity, supportive care.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Life-Threatening</h4>
          <ul>
            <li><strong>MAOIs:</strong> Serotonin syndrome, hypertensive crisis - can be fatal</li>
            <li><strong>Alcohol:</strong> Severe CNS depression, respiratory depression, death</li>
            <li><strong>Benzodiazepines:</strong> Dangerous respiratory depression</li>
            <li><strong>Opioids:</strong> Extreme sedation, respiratory failure</li>
            <li><strong>Tramadol:</strong> Seizure risk, serotonin syndrome</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>SSRIs:</strong> Serotonin syndrome risk</li>
            <li><strong>Anticholinergic drugs:</strong> Additive anticholinergic toxicity</li>
            <li><strong>QT-prolonging drugs:</strong> Increased cardiac arrhythmia risk</li>
            <li><strong>Sympathomimetics:</strong> Hypertensive crisis</li>
            <li><strong>Antihistamines:</strong> Excessive sedation</li>
          </ul>
        </div>
        
        <div class="interaction medical">
          <h4>üè• Medical Monitoring Required</h4>
          <ul>
            <li><strong>CYP2D6 inhibitors:</strong> Increased amitriptyline levels (fluoxetine, paroxetine)</li>
            <li><strong>Warfarin:</strong> Increased bleeding risk</li>
            <li><strong>Antiarrhythmics:</strong> Additive cardiac effects</li>
            <li><strong>Thyroid hormones:</strong> Enhanced tricyclic effects</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Prescription medication</strong> - Requires prescription from licensed physician. No controlled substance scheduling, but regulated as prescription drug.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Prescription Only Medicine (POM)</strong> - Available only with prescription. Not controlled under Misuse of Drugs Act.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá™üá∫ European Union</h4>
            <p><strong>Prescription medication</strong> - Regulated as prescription-only medicine throughout EU. Some countries classify as Schedule IV.</p>
          </div>
          <div class="jurisdiction">
            <h4>üåè Global Status</h4>
            <p><strong>Prescription medication</strong> - Available by prescription in most countries. Some nations classify as controlled substance due to abuse potential.</p>
          </div>
        </div>
        
        <div class="legal-consequences">
          <h4>‚öñÔ∏è Legal Issues</h4>
          <ul>
            <li><strong>Prescription fraud:</strong> Illegal to obtain without valid prescription</li>
            <li><strong>Distribution:</strong> Sharing or selling prescription medications is illegal</li>
            <li><strong>Driving under influence:</strong> Can result in DUI charges</li>
            <li><strong>Professional consequences:</strong> Medical professionals face license issues for abuse</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1961</span>
          <p>First synthesized by scientists at Merck, initially called MK-231</p>
        </div>
        <div class="history-event">
          <span class="year">1962</span>
          <p>Clinical trials begin for depression treatment</p>
        </div>
        <div class="history-event">
          <span class="year">1967</span>
          <p>FDA approval in US as Elavil for depression treatment</p>
        </div>
        <div class="history-event">
          <span class="year">1970s</span>
          <p>Becomes widely prescribed antidepressant, peak popularity</p>
        </div>
        <div class="history-event">
          <span class="year">1980s</span>
          <p>Overdose concerns grow, off-label use for chronic pain increases</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>SSRIs largely replace tricyclics as first-line antidepressants</p>
        </div>
        <div class="history-event">
          <span class="year">2000s-present</span>
          <p>Remains important for treatment-resistant depression and chronic pain</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Medical & Cultural Context</h4>
        <p>Amitriptyline represented a major breakthrough in depression treatment in the 1960s-70s. Before SSRIs, tricyclics like amitriptyline were the primary pharmacological treatment for depression. The drug gained notoriety for both its effectiveness and its dangerous overdose potential, leading to its use in suicide attempts.</p>
        
        <h4>Recreational Use Patterns</h4>
        <p>While not a common recreational drug, amitriptyline is sometimes abused for its sedative effects or obtained through prescription fraud. Its use as a "downer" is dangerous due to the narrow margin between intoxicating and toxic doses.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research & Medical Uses</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Treatment-Resistant Depression</h4>
          <p>Research continues into amitriptyline's role in depression that doesn't respond to modern antidepressants. Studies examine optimal dosing and combination strategies.</p>
        </div>
        
        <div class="research-item">
          <h4>Chronic Pain Management</h4>
          <p>Extensive research supports low-dose amitriptyline for neuropathic pain, fibromyalgia, and chronic headaches. Lower doses (10-75mg) avoid many psychiatric side effects.</p>
        </div>
        
        <div class="research-item">
          <h4>Sleep Disorders</h4>
          <p>Studies examine amitriptyline's effectiveness for insomnia, particularly when combined with chronic pain or depression. Research focuses on optimal dosing for sleep benefits.</p>
        </div>
        
        <div class="research-item">
          <h4>Overdose Treatment</h4>
          <p>Ongoing research into optimal treatment protocols for tricyclic overdose, including sodium bicarbonate therapy and cardiac monitoring approaches.</p>
        </div>
      </div>

      <div class="medical-uses">
        <h4>üè• Current Medical Uses</h4>
        <ul>
          <li><strong>Major Depression:</strong> Second or third-line treatment after SSRIs</li>
          <li><strong>Neuropathic Pain:</strong> First-line treatment for diabetic neuropathy, post-herpetic neuralgia</li>
          <li><strong>Migraine Prevention:</strong> Effective prophylactic treatment</li>
          <li><strong>Fibromyalgia:</strong> Pain and sleep improvement</li>
          <li><strong>Irritable Bowel Syndrome:</strong> Low-dose treatment for pain and bowel symptoms</li>
          <li><strong>Insomnia:</strong> Off-label use, particularly with comorbid pain or depression</li>
        </ul>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Crisis & Emergency</h4>
        <ul>
          <li><strong>Emergency:</strong> Call 911 for overdose or cardiac symptoms</li>
          <li><strong>Poison Control:</strong> 1-800-222-1222 (US)</li>
          <li><strong>Suicide Prevention:</strong> 988 (US) or local crisis line</li>
          <li><strong>Crisis Text Line:</strong> Text HOME to 741741</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://www.nami.org/">NAMI</a> - Mental health education and support</li>
          <li><a href="https://www.nimh.nih.gov/">NIMH</a> - Depression research and information</li>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a> - Medical research database</li>
          <li>Local mental health professionals</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Addiction & Abuse</h4>
        <ul>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Treatment locator and resources</li>
          <li><a href="https://www.na.org/">Narcotics Anonymous</a> - Recovery support</li>
          <li><a href="https://prescriptionabuse.org/">Partnership to End Addiction</a> - Prescription drug abuse resources</li>
          <li>Local addiction treatment centers</li>
        </ul>
      </div>
    </div>
  </div>

  <div class="medical-warning-footer">
    <h3>‚öïÔ∏è Medical Disclaimer</h3>
    <p>Amitriptyline is a legitimate prescription medication with important therapeutic uses when properly prescribed and monitored by healthcare professionals. This information is for educational purposes only and should not replace medical advice. The recreational use of amitriptyline is extremely dangerous due to its narrow therapeutic window and significant overdose potential.</p>
    
    <p><strong>If you are struggling with depression, chronic pain, or considering recreational use of prescription medications, please consult with a healthcare provider or mental health professional.</strong></p>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/profile.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/friends.js"></script>
</body>
</html>